Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
Trials of interest in newly diagnosed myeloma presented at IMS 2024
03:48
|
Download MP3
Related Videos
5:11
iStopMM: the psychological effects of MGUS screening and changes to clinical presentation of myeloma
3:08
Welcome to the Video Journal of Hematology & Hematological Oncology 🎥🩸
1:42
The future of CLL treatment: aiming for long-lasting remission
5:21
Challenges in the treatment and management of ET and the need to improve therapeutic approaches
2:13
Personalizing the timing of SCT in patients with myelofibrosis
1:31
Frontline treatment for CLL: the changing paradigm
1:36
The use of outpatient cilta-cel in the treatment of multiple myeloma
0:44
Early detection and interception across hematological cancers
1:01
Treatment-free remission after second-generation TKI treatment in CML
2:59
The tests that are needed to make a definitive diagnosis of CLL
3:40
Master class in transplantation and hematology: highlights
6:54
Biomarker-guided treatment of CLL in the chemo-free era
2:55
A model including CD49d expression to predict outcomes in patients with CLL treated with ibrutinib
1:38
The use of golcadomide in combination with R-CHOP for the treatment of aggressive B-cell lymphomas
2:26
An insight into the aims of the Eurasian Hematology-Oncology Group
2:38
Cardiotoxicity associated with MCL-1 inhibition for R/R hematologic malignancies
1:16
Mechanisms of resistance to the TKI asciminib in CML
1:23
The cardiac rhythm in thalassemia: increased incidence of atrial fibrillation and stroke
3:00
The new criteria for defining high-risk multiple myeloma
1:13
Molecular MRD as a prognostic marker for AML patients with mutated CEBPA
5:11
2:55
5:11 2:55 5:11 2:55
